Genetic testing accuracy: needle biopsy vs. surgery
Part of Cancer, Hormones & metabolism clinical trials.
This study compares genetic testing results from a small needle biopsy to those from the surgically removed thyroid tissue. It aims to see if the biopsy alone can accurately predict the cancer's genetics, which could help guide treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a thyroid nodule that is larger than 1 cm (about the size of a pea) on imaging.
- Your biopsy showed either a high suspicion for cancer (Bethesda V or VI) or an uncertain result (Bethesda III or IV) with specific genetic changes.
- You are healthy enough for surgery (thyroidectomy).
- You have not had radiation to your neck in the past.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a genetic test (Thyroid GuidePx) can help doctors decide the best surgical approach for thyroid nodules that may be cancerous. By identifying genetic markers before surgery, the test may help avoid unnecessary extensive surgery or ensure appropriate treatment.
This trial studies the genetic “mutations” in papillary thyroid cancer tumors using tumor tissue. The goal is to better describe tumor genetic patterns, which may help researchers understand the disease.
This study uses ultrasound images and a quick gene test to predict certain gene changes and cancer spread in people with thyroid cancer. If you are planning to have surgery to remove your thyroid, your ultrasound images and a small tissue sample will be analyzed to help guide treatment.
This study uses special tests on cells from a fine-needle aspiration to help doctors tell with more certainty whether a suspicious spot on the thyroid is cancer. It may help avoid unnecessary surgery.
This study tests a new tool (ThyroidPrint) to see if it can accurately predict whether a thyroid nodule with unclear biopsy results is benign or malignant. The goal is to help doctors and patients decide on surgery more confidently.
This study compares a less invasive procedure (microwave ablation) with traditional surgery for treating a small, low-risk papillary thyroid cancer. If you have a single, small tumor with certain low-risk gene changes, you might be able to avoid surgery and have a quicker recovery.
Hear when a new Papillary Thyroid Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.